Seven new procedure codes were added to private reimbursement schedule in England in August

20

Sep 2017

The Clinical Coding and Schedule Development (CCSD) develops and maintains procedural and diagnostics nomenclature for private payers in England. Once codes are added to the Schedule, a private insurance company can develop reimbursement tariff for these procedures and tests.

The CCSD Group has approved the following procedure codes for publication to the CCSD Schedule in August:

  • Aqueous shunt tube surgery for glaucoma (including topical or local anaesthetic) including donor patch - unilateral (C6051)
  • Aqueous shunt tube surgery for glaucoma (including topical or local anaesthetic) including donor patch - bilateral (C6052)
  • Fat plug myringoplasty (D1421)
  • Transforaminal epidural (lumbar) (A5293)
  • Transforaminal epidural (caudal) (A5294)
  • Transforaminal epidural (thoracic) (A5292)
  • Transforaminal epidural (cervical) (A5291)

The following requests have been declined or withdrawn:

  • Biopsy of skin, suspicious skin lesion or subcutaneous tissue (S1500) – due to sufficient current narrative
  • Injection into subcutaneous tissue under local anaesthetic (S5210) and two or more injections into subcutaneous tissue under local anaesthetic (S5240) – the Working Group would prefer new codes for any activity previously covered under S5210 and S5240.

See full information here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

Tags
UK
Private health insurance

The latest related news

NHS Insights Prioritisation Programme in England

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

 Read more
New procedure and diagnostic codes added to the private reimbursement schedule in England

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

 Read more
NHSX becomes a part of the new NHS England Transformation Directorate

01

Mar 2022

On February 04, 2022, NHSX announced merging with NHS Digital into the new Transformation Directorate at NHS England. NHSX's mission will remain the same - to drive the digital transformation of the NHS and social care.

 Read more
Updated 2021/22 National Genomic Test Directory for rare and inherited diseases in England

16

Feb 2022

On February 02, 2022, NHS England updated the 2021/22 National Genomic Test Directory for rare and inherited diseases, initially published in October 2021. No new codes were introduced. Amendments were made in 77 codes, including changing the test method, commissioning category, specialist group.

 Read more
New advice service for developers and adopters of artificial intelligence and data-driven technologies in England

11

Feb 2022

A new multi-agency advisory service (MAAS) is currently under development by the National Institute of Health and Care Excellence (NICE). This new cross-regulatory service will be a “one-stop-shop” for support, information, and guidance on the regulation and evaluation of AI technologies. The launch of the new service is scheduled for summer 2022.

 Read more